Article Details
Retrieved on: 2017-12-06 22:35:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>based biotechnology developing next-generation cell and gene therapies, raised $49.5 million in Series A funding led by GV, and was joined by investors including <b>Atlas Venture</b>, Takeda Ventures Inc., Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here